Rethinking Legionella pneumophila type IV pili and their roles in intracellular infection

重新思考嗜肺军团菌 IV 型菌毛及其在细胞内感染中的作用

基本信息

项目摘要

PROJECT SUMMARY / ABSTRACT Legionella pneumophila (Lp) is the agent of Legionnaires disease, an oft-fatal form of pneumonia that is increasing in incidence. In natural and man-made aquatic habitats, Lp flourishes as an intracellular parasite of amoebae, often in biofilms. Following the inhalation of Lp-contaminated water droplets, the pathogen grows primarily in alveolar macrophages and secondarily in lung epithelia. Relatively little is known about Lp pili or the bases of Lp attachment to human cells and other surfaces. Early electron microscopy revealed different filaments emanating from the Lp surface, suggesting that Lp expresses “long” and “short” pili. Genomic analysis done by others and us gradually found that Lp has all the genes that typically encode a type IV pilus (T4P) apparatus affirming that at least some Lp pili are T4P. Recently, we uncovered pilA2, a previously unrecognized gene predicted to encode a protein with similarity to major building blocks (type IVa major pilins) of other T4P-expressing bacteria. Immunofluorescence microscopy has revealed that PilA2 exists prominently across the entire length of visualized Lp pili, affirming its role as a major pilin. Intriguingly, we discovered adjacent to pilA2 a second type IVa major pilin gene, pilA1. From our RNA-Seq work, both pilA1 and pilA2 are expressed by Lp growing in liquid and solid media. Moreover, based on the behavior of a pilA1 pilA2 double mutant, pilA1 and pilA2 each promote twitching, a form of surface associated motility. However, whereas a pilA2 mutant was impaired for DNA uptake and infection of Acanthamoeba castellanii (Ac) but hyper- aggregative, a pilA1 mutant was impaired for auto-aggregation but normal for DNA uptake and Ac infection. Thus, we hypothesize that i) PilA2 majorly comprises T4aP that promote competence, twitching, and infection of Ac, but are inhibitory to Lp aggregation and ii) that PilA1 forms distinct T4aP that promote aggregation as well as twitching motility but are not needed for DNA uptake or Ac infection. Thus, overturning long-standing perspectives, our work provides the first genetic evidence that Lp elaborates more than one type of functional T4P, compatible with the “old” EM data that had shown two sizes of pili on the Lp surface. This proposal aims to i) confirm if PilA1 and PilA2 assemble, as major pilins, into distinct Lp T4aP and ii) discern if PilA1-T4aP and PilA2-T4aP are functionally different in the context of adherence to and infection of human macrophages and epithelia, infection of various amoebae that help transmit Lp to humans, and biofilm formation, which is another key attribute of Lp in vivo and in the environment. This work will i) increase our knowledge of Lp, a growing clinical problem, ii) define new forms of T4P and infection pathways, iii) have implications for other pathogens that use T4P or are intracellular parasites, and iv) suggest new targets for disease treatment or prevention.
项目总结/摘要 嗜肺军团菌(Lp)是军团菌病的病原体,军团菌病是一种致命的肺炎, 发病率上升。在自然和人造水生生境中,Lp作为细胞内寄生虫寄生于 变形虫,通常在生物膜中。在吸入被Lp污染的水滴后,病原体生长 主要在肺泡巨噬细胞中,其次在肺上皮细胞中。关于Lp皮利或其受体的了解相对较少。 Lp附着于人体细胞和其他表面的碱基。早期的电子显微镜显示 纤维从Lp表面发出,表明Lp表达“长”和“短”皮利。基因组 我们和其他人所做的分析逐渐发现,Lp具有典型编码IV型菌毛的所有基因 (T4P)确认至少一些Lp皮利是T4 P的装置。最近,我们发现了pilA 2, 预测编码与主要结构单元(IVa型主要菌毛蛋白)相似的蛋白质的未识别基因 其他表达T4 P的细菌。免疫荧光显微镜观察显示,PilA 2在细胞内的表达量显著增加, 在整个长度的可视化Lp皮利,肯定其作为一个主要的菌毛蛋白的作用。有趣的是,我们发现 与pilA 2相邻的是第二种IVa型主要菌毛蛋白基因pilA 1。根据我们的RNA-Seq工作,pilA 1和pilA 2都是 由在液体和固体培养基中生长的Lp表达。此外,基于pilA 1 pilA 2双链的行为, 突变体pilA 1和pilA 2各自促进抽搐,这是一种表面相关运动形式。然而,尽管A pilA 2突变体对卡氏阿米巴(Ac)的DNA摄取和感染有损害,但对pilA 2突变体的DNA摄取和感染无影响,而对pilA 2突变体的DNA摄取和感染无影响。 聚集性,pilA 1突变体受损的自动聚集,但正常的DNA摄取和Ac感染。 因此,我们假设i)PilA 2主要包含促进感受态、抽搐和感染的T4 aP ii)PilA 1形成不同的T4 aP,其促进聚集, 以及抽搐运动,但不需要DNA摄取或Ac感染。因此,推翻长期以来 我们的工作提供了第一个遗传学证据,表明Lp阐述了一种以上的功能性 T4 P,与“旧”EM数据兼容,该数据显示Lp表面上有两种尺寸的皮利。这项建议旨在 i)确认PilA 1和PilA 2是否作为主要菌毛组装成不同的Lp T4 aP,以及ii)辨别PilA 1-T4 aP和 PilA 2-T4 aP在粘附和感染人巨噬细胞的情况下功能不同, 上皮细胞,感染各种阿米巴原虫,帮助将Lp传播给人类,以及生物膜形成,这是另一个 Lp在体内和环境中的关键属性。这项工作将i)增加我们对Lp的认识, 临床问题,ii)定义新形式的T4 P和感染途径,iii)对其他病原体有影响 使用T4 P或为细胞内寄生虫的细胞,和iv)提出用于疾病治疗或预防的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS P CIANCIOTTO其他文献

NICHOLAS P CIANCIOTTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS P CIANCIOTTO', 18)}}的其他基金

Stenotrophomonas maltophilia TfcA and TfcB: Antibacterial T4SS effectors from an emerging human pathogen
嗜麦芽寡养单胞菌 TfcA 和 TfcB:来自新兴人类病原体的抗菌 T4SS 效应子
  • 批准号:
    10661253
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Mucinases as Emerging Players in Legionella pneumophila Pathogenesis
粘蛋白酶作为嗜肺军团菌发病机制中的新兴参与者
  • 批准号:
    10643053
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Siderophores of Legionella pneumophila
嗜肺军团菌的铁载体
  • 批准号:
    10172838
  • 财政年份:
    2018
  • 资助金额:
    $ 23.06万
  • 项目类别:
Virulence Mechanisms of the Emerging Pathogen Stenotrophomonas maltophilia
新兴病原体嗜麦芽寡养单胞菌的毒力机制
  • 批准号:
    8867607
  • 财政年份:
    2015
  • 资助金额:
    $ 23.06万
  • 项目类别:
CRISPR Cas genes and Legionella pneumophila infection
CRISPR Cas基因与嗜肺军团菌感染
  • 批准号:
    8424733
  • 财政年份:
    2013
  • 资助金额:
    $ 23.06万
  • 项目类别:
CRISPR Cas genes and Legionella pneumophila infection
CRISPR Cas基因与嗜肺军团菌感染
  • 批准号:
    8733513
  • 财政年份:
    2013
  • 资助金额:
    $ 23.06万
  • 项目类别:
Pyomelanin and Legionella pneumophila Infection
黑色素和嗜肺军团菌感染
  • 批准号:
    7940261
  • 财政年份:
    2010
  • 资助金额:
    $ 23.06万
  • 项目类别:
Pyomelanin and Legionella pneumophila Infection
黑色素和嗜肺军团菌感染
  • 批准号:
    8076237
  • 财政年份:
    2010
  • 资助金额:
    $ 23.06万
  • 项目类别:
Bacterial chitinases as new virulence factors
细菌几丁质酶作为新的毒力因子
  • 批准号:
    7594923
  • 财政年份:
    2009
  • 资助金额:
    $ 23.06万
  • 项目类别:
Bacterial chitinases as new virulence factors
细菌几丁质酶作为新的毒力因子
  • 批准号:
    7754036
  • 财政年份:
    2009
  • 资助金额:
    $ 23.06万
  • 项目类别:

相似海外基金

A machine learning-based screen of marine natural products to identify new leads for the treatment of Acanthamoeba eye infection
基于机器学习的海洋天然产品筛选,以确定治疗棘阿米巴眼部感染的新线索
  • 批准号:
    10669249
  • 财政年份:
    2022
  • 资助金额:
    $ 23.06万
  • 项目类别:
A machine learning-based screen of marine natural products to identify new leads for the treatment of Acanthamoeba eye infection
基于机器学习的海洋天然产品筛选,以确定治疗棘阿米巴眼部感染的新线索
  • 批准号:
    10511577
  • 财政年份:
    2022
  • 资助金额:
    $ 23.06万
  • 项目类别:
Latrunculin B as a new drug lead for the treatment of Acanthamoeba keratitis
Latrunculin B 作为治疗棘阿米巴角膜炎的新药先导物
  • 批准号:
    10192287
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Investigation of the pathogenic mechanisms of Acanthamoeba Keratitis
棘阿米巴角膜炎发病机制的探讨
  • 批准号:
    18K16938
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latrunculin B as a new drug lead for the treatment of Acanthamoeba keratitis
Latrunculin B 作为治疗棘阿米巴角膜炎的新药先导物
  • 批准号:
    10391540
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Intrasurvival methanism of Escherichia albertii in Acanthamoeba
棘阿米巴中艾伯氏埃希菌的存活内产甲烷作用
  • 批准号:
    20K07498
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Amoeba-associated microorganisms (AAMs) of Acanthamoeba in house dust and its potential human health risk
室内灰尘中棘阿米巴阿米巴相关微生物(AAM)及其对人类健康的潜在风险
  • 批准号:
    18K11687
  • 财政年份:
    2018
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of early diagnostic method and elucidation of pathogenic mechanism for Acanthamoeba keratitis
棘阿米巴角膜炎早期诊断方法的建立及致病机制的阐明
  • 批准号:
    16K20310
  • 财政年份:
    2016
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The efficacy of the photodynamic therapy (PDT) against Acanthamoeba keratitis
光动力疗法(PDT)治疗棘阿米巴角膜炎的疗效
  • 批准号:
    25861635
  • 财政年份:
    2013
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Early diagnosis with in vivo laser confocal microscopy incytomegalovirus corneal endotheliitis and Acanthamoeba keratitis
体内激光共聚焦显微镜早期诊断巨细胞病毒角膜内皮炎和棘阿米巴角膜炎
  • 批准号:
    23890072
  • 财政年份:
    2011
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了